Description
General Description
ALC-0159 is a PEG-lipid excipient used in lipid nanoparticle (LNP) formulations to improve colloidal stability, control particle size, reduce aggregation, and enhance formulation performance. It is one of the PEGylated lipids utilized in mRNA-LNP delivery systems and is widely employed in nucleic acid delivery research.
The PEG chain provides steric stabilization and prolonged circulation properties, while the lipid anchor enables incorporation into lipid nanoparticle and liposome formulations.
Key Properties
- PEGylated lipid for LNP formulations
- PEG molecular weight approximately 2000 Da
- Provides steric stabilization
- Reduces nanoparticle aggregation
- Improves colloidal stability
- Suitable for nucleic acid delivery applications
Applications
- Lipid nanoparticle (LNP) formulations
- mRNA delivery
- Vaccine research
- Gene therapy research
- siRNA delivery
- Liposome formulation
- Nanomedicine development
Functional Overview
ALC-0159 functions as a PEG-lipid excipient that stabilizes lipid nanoparticles during formulation and storage. The PEG segment helps minimize particle aggregation and improves nanoparticle dispersion characteristics.
Summary
ALC-0159 is a widely used PEGylated lipid for lipid nanoparticle engineering, nucleic acid delivery, and advanced nanomedicine research applications
